122 related articles for article (PubMed ID: 29437570)
1. Immunosuppression by a subconjunctival implant releasing dexamethasone in a rabbit model of penetrating keratoplasty.
Crouzet E; Garcin T; Gauthier AS; He Z; Perrache C; Delavenne X; Basset T; Peoc'h M; Gain P; Thuret G
Br J Ophthalmol; 2018 May; 102(5):692-699. PubMed ID: 29437570
[TBL] [Abstract][Full Text] [Related]
2. Dropless penetrating keratoplasty using a subconjunctival dexamethasone implant: safety pilot study.
Trone MC; Poinard S; Crouzet E; Garcin T; Mentek M; Forest F; Matray M; Thuret G; Gain P
Br J Ophthalmol; 2023 Feb; 107(2):181-186. PubMed ID: 34426402
[TBL] [Abstract][Full Text] [Related]
3. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
Xin M; Wang T; Shi W; Wu X
J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
[TBL] [Abstract][Full Text] [Related]
4. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
Xi XH; Qin B; Jiang DY
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.
Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY
J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198
[TBL] [Abstract][Full Text] [Related]
7. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
8. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
9. Long-term resolution of immunological graft rejection after a dexamethasone intravitreal implant.
Vinciguerra P; Albé E; Vinciguerra R; Romano MR; Trazza S; Mastropasqua L; Epstein D
Cornea; 2015 Apr; 34(4):471-4. PubMed ID: 25742389
[TBL] [Abstract][Full Text] [Related]
10. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty].
Gong YB; Lu XH; Ke XY; Zhou J; Yuan W; Tang MF; Luo XY; Cui GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1523-9. PubMed ID: 18819859
[TBL] [Abstract][Full Text] [Related]
11. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
Minamoto A; Sakata H; Okada K; Fujihara M
Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
[TBL] [Abstract][Full Text] [Related]
12. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
[TBL] [Abstract][Full Text] [Related]
13. [Penetrating keratoplasty in high-risk children: prevention of graft rejection].
Pleskova AV; Khvatova AV
Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection.
Lee SS; Kim H; Wang NS; Bungay PM; Gilger BC; Yuan P; Kim J; Csaky KG; Robinson MR
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2023-9. PubMed ID: 17460256
[TBL] [Abstract][Full Text] [Related]
15. Effect of the TLR2/MyD88/NF-κB axis on corneal allograft rejection after penetrating keratoplasty.
Wu W; Yu S; Feng S; Yang J; Lu X
J Recept Signal Transduct Res; 2016; 36(1):45-52. PubMed ID: 25800037
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of trichostatin on allograft rejection of corneal transplantation in rats.
Maimaitiming R; Yang X; Wupuer K; Ye N; Pan Z
Int J Clin Exp Med; 2015; 8(8):12424-9. PubMed ID: 26550154
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
Unal M; Yücel I
Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
Birnbaum F; Mayweg S; Reis A; Böhringer D; Seitz B; Engelmann K; Messmer EM; Reinhard T
Eye (Lond); 2009 Nov; 23(11):2063-70. PubMed ID: 19151659
[TBL] [Abstract][Full Text] [Related]
19. [Topical immunosuppressives after penetrating keratoplasty].
Birnbaum F; Reis A; Reinhard T
Ophthalmologe; 2007 May; 104(5):381-7. PubMed ID: 17387481
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
Chow SP; Cook SD; Tole DM
Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
